{"id":"https://openalex.org/W2767154475","doi":"https://doi.org/10.1097/ftd.0000000000000457","title":"Serum Concentrations of Paliperidone After Administration of the Long-Acting Injectable Formulation","display_name":"Serum Concentrations of Paliperidone After Administration of the Long-Acting Injectable Formulation","publication_year":2017,"publication_date":"2017-10-17","ids":{"openalex":"https://openalex.org/W2767154475","doi":"https://doi.org/10.1097/ftd.0000000000000457","mag":"2767154475","pmid":"https://pubmed.ncbi.nlm.nih.gov/29040230","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/5690301"},"language":"en","primary_location":{"id":"doi:10.1097/ftd.0000000000000457","doi":"https://doi.org/10.1097/ftd.0000000000000457","is_oa":true,"landing_page_url":"https://doi.org/10.1097/ftd.0000000000000457","pdf_url":null,"source":{"id":"https://openalex.org/S179268941","display_name":"Therapeutic Drug Monitoring","issn_l":"0163-4356","issn":["0163-4356","1536-3694"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Therapeutic Drug Monitoring","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1097/ftd.0000000000000457","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5061283848","display_name":"Arne Helland","orcid":"https://orcid.org/0000-0002-9373-1253","observed_orcids":["https://orcid.org/0000-0002-9373-1253"]},"institutions":[{"id":"https://openalex.org/I204778367","display_name":"Norwegian University of Science and Technology","ror":"https://ror.org/05xg72x27","country_code":"NO","type":"education","lineage":["https://openalex.org/I204778367"]},{"id":"https://openalex.org/I4210104358","display_name":"St Olav's University Hospital","ror":"https://ror.org/01a4hbq44","country_code":"NO","type":"healthcare","lineage":["https://openalex.org/I4210104358"]}],"countries":["NO"],"is_corresponding":true,"raw_author_name":"Arne Helland","raw_affiliation_strings":["Department of Clinical Pharmacology, St. Olav University Hospital; and","Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacology, St. Olav University Hospital; and","institution_ids":["https://openalex.org/I4210104358"]},{"raw_affiliation_string":"Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway","institution_ids":["https://openalex.org/I204778367"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5031025442","display_name":"Olav Spigset","orcid":"https://orcid.org/0000-0001-7902-9014","observed_orcids":["https://orcid.org/0000-0001-7902-9014"]},"institutions":[{"id":"https://openalex.org/I204778367","display_name":"Norwegian University of Science and Technology","ror":"https://ror.org/05xg72x27","country_code":"NO","type":"education","lineage":["https://openalex.org/I204778367"]},{"id":"https://openalex.org/I4210104358","display_name":"St Olav's University Hospital","ror":"https://ror.org/01a4hbq44","country_code":"NO","type":"healthcare","lineage":["https://openalex.org/I4210104358"]}],"countries":["NO"],"is_corresponding":true,"raw_author_name":"Olav Spigset","raw_affiliation_strings":["Department of Clinical Pharmacology, St. Olav University Hospital; and","Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacology, St. Olav University Hospital; and","institution_ids":["https://openalex.org/I4210104358"]},{"raw_affiliation_string":"Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway","institution_ids":["https://openalex.org/I204778367"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5031025442","https://openalex.org/A5061283848"],"corresponding_institution_ids":["https://openalex.org/I204778367","https://openalex.org/I4210104358"],"apc_list":null,"apc_paid":null,"fwci":1.4441,"has_fulltext":false,"cited_by_count":27,"citation_normalized_percentile":{"value":0.80810654,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"39","issue":"6","first_page":"659","last_page":"662"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.7602999806404114,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.7602999806404114,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.10260000079870224,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.011500000022351742,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/paliperidone","display_name":"paliperidone","score":1.0},{"id":"https://openalex.org/keywords/long-acting-injectable-antipsychotics","display_name":"long-acting injectable antipsychotics","score":0.9750000238418579},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8560000061988831},{"id":"https://openalex.org/keywords/carbamazepine","display_name":"carbamazepine","score":0.8460000157356262},{"id":"https://openalex.org/keywords/p-glycoprotein-induction","display_name":"P-glycoprotein induction","score":0.8619999885559082},{"id":"https://openalex.org/keywords/age-effects","display_name":"age effects","score":0.6610000133514404},{"id":"https://openalex.org/keywords/inter-individual-variability","display_name":"interindividual variability","score":0.8949999809265137},{"id":"https://openalex.org/keywords/atypical-antipsychotics","display_name":"atypical antipsychotics","score":0.7730000019073486}],"concepts":[{"id":"https://openalex.org/C2777126507","wikidata":"https://www.wikidata.org/wiki/Q423292","display_name":"Paliperidone","level":4,"score":0.981472909450531},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.695851743221283},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.6269569396972656},{"id":"https://openalex.org/C2908997079","wikidata":"https://www.wikidata.org/wiki/Q27157250","display_name":"Paliperidone Palmitate","level":4,"score":0.5606313943862915},{"id":"https://openalex.org/C2780272996","wikidata":"https://www.wikidata.org/wiki/Q1261151","display_name":"Therapeutic drug monitoring","level":3,"score":0.5531498193740845},{"id":"https://openalex.org/C19831878","wikidata":"https://www.wikidata.org/wiki/Q659446","display_name":"Therapeutic index","level":3,"score":0.5531203746795654},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.5299018025398254},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4891407787799835},{"id":"https://openalex.org/C2779253243","wikidata":"https://www.wikidata.org/wiki/Q410412","display_name":"Carbamazepine","level":3,"score":0.457184761762619},{"id":"https://openalex.org/C122048520","wikidata":"https://www.wikidata.org/wiki/Q2913954","display_name":"Percentile","level":2,"score":0.4313696622848511},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.33873090147972107},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.33576124906539917},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.322603702545166},{"id":"https://openalex.org/C2780057945","wikidata":"https://www.wikidata.org/wiki/Q412443","display_name":"Risperidone","level":3,"score":0.21051323413848877},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.18390756845474243},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.13923314213752747},{"id":"https://openalex.org/C2778186239","wikidata":"https://www.wikidata.org/wiki/Q41571","display_name":"Epilepsy","level":2,"score":0.08974301815032959},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.0},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.0},{"id":"https://openalex.org/C105795698","wikidata":"https://www.wikidata.org/wiki/Q12483","display_name":"Statistics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000068882","descriptor_name":"Paliperidone Palmitate","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000068882","descriptor_name":"Paliperidone Palmitate","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D000068882","descriptor_name":"Paliperidone Palmitate","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003692","descriptor_name":"Delayed-Action Preparations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1097/ftd.0000000000000457","doi":"https://doi.org/10.1097/ftd.0000000000000457","is_oa":true,"landing_page_url":"https://doi.org/10.1097/ftd.0000000000000457","pdf_url":null,"source":{"id":"https://openalex.org/S179268941","display_name":"Therapeutic Drug Monitoring","issn_l":"0163-4356","issn":["0163-4356","1536-3694"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Therapeutic Drug Monitoring","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:5690301","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/5690301","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Ther Drug Monit","raw_type":"Text"},{"id":"pmid:29040230","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/29040230","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Therapeutic drug monitoring","raw_type":"Journal Article"},{"id":"pmh:oai:ntnuopen.ntnu.no:11250/2478165","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/11250/2478165","pdf_url":null,"source":{"id":"https://openalex.org/S7407064446","display_name":"NORA - Norwegian Open Research Archives","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"659-662","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.1097/ftd.0000000000000457","doi":"https://doi.org/10.1097/ftd.0000000000000457","is_oa":true,"landing_page_url":"https://doi.org/10.1097/ftd.0000000000000457","pdf_url":null,"source":{"id":"https://openalex.org/S179268941","display_name":"Therapeutic Drug Monitoring","issn_l":"0163-4356","issn":["0163-4356","1536-3694"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Therapeutic Drug Monitoring","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":20,"referenced_works":["https://openalex.org/W1499179036","https://openalex.org/W1906145619","https://openalex.org/W1954706707","https://openalex.org/W1969738024","https://openalex.org/W1994870822","https://openalex.org/W2002564282","https://openalex.org/W2014558798","https://openalex.org/W2069799317","https://openalex.org/W2075756716","https://openalex.org/W2076818471","https://openalex.org/W2080340726","https://openalex.org/W2081680186","https://openalex.org/W2114098531","https://openalex.org/W2119650801","https://openalex.org/W2125138227","https://openalex.org/W2127664594","https://openalex.org/W2127872656","https://openalex.org/W2128523748","https://openalex.org/W2136924078","https://openalex.org/W2219812044"],"related_works":["https://openalex.org/W3132898524","https://openalex.org/W4394253224","https://openalex.org/W2718238251","https://openalex.org/W4200428522","https://openalex.org/W1994870822","https://openalex.org/W2736194893","https://openalex.org/W3172886187","https://openalex.org/W4230478003","https://openalex.org/W4393005065","https://openalex.org/W1490484843"],"abstract_inverted_index":{"BACKGROUND:":[0],"The":[1,15,70,79,134,204,235],"pharmacokinetics":[2,232],"of":[3,17,30,58,84,94,126,138,143,154,163,172,182,188,198,225,233],"long-acting":[4],"intramuscular":[5,152],"paliperidone":[6,31,59,85,139],"in":[7,45,103,114,211,242],"a":[8,35,90,161,170,180,207],"naturalistic":[9],"setting":[10],"is":[11],"not":[12],"well":[13],"documented.":[14],"objective":[16],"this":[18],"study":[19,236],"was":[20,73,86],"to":[21,252],"investigate":[22],"the":[23,64,117,131,141,144,189,194,216,222,231],"relationship":[24],"between":[25],"dose":[26,72,129,145,153,162,171,181],"and":[27,51,109,176,220,227],"serum":[28,98,136,213],"concentrations":[29,99,137,214],"using":[32],"data":[33,205],"from":[34,48,63],"routine":[36],"therapeutic":[37,65,196],"drug":[38,66],"monitoring":[39,67],"service.":[40],"METHODS:":[41],"Serum":[42],"concentration":[43],"measurements":[44,190],"310":[46],"samples":[47],"110":[49],"male":[50],"75":[52,164],"female":[53],"patients":[54,104,115],"receiving":[55],"depot":[56],"injections":[57],"were":[60,100,122,147,191],"retrospectively":[61],"retrieved":[62],"database.":[68],"RESULTS:":[69],"median":[71,80,135],"100":[74,173],"mg":[75],"every":[76],"28":[77],"days.":[78],"concentration/dose":[81],"(C/D)":[82],"ratio":[83],"16.1":[87],"(nmol/L)/(mg/d),":[88],"with":[89],"10-90":[91,217],"percentile":[92,218],"range":[93,197,219],"7.8-31.0":[95],"(nmol/L)/(mg/d).":[96],"Dose-adjusted":[97],"33%":[101],"higher":[102],"65":[105],"years":[106],"or":[107,128],"older":[108],"more":[110],"than":[111,193,250],"50%":[112],"lower":[113,192],"taking":[116],"p-glycoprotein":[118,228],"inducer":[119],"carbamazepine.":[120],"There":[121],"no":[123],"significant":[124,223],"effects":[125,224],"sex":[127],"on":[130,230],"C/D":[132],"ratio.":[133],"at":[140,150,240],"end":[142],"interval":[146],"31":[148],"nmol/L":[149,159,168,178],"an":[151],"50":[155],"mg/28":[156,165,174,184],"d,":[157,166,175],"53":[158],"after":[160,169,179],"59":[167],"93":[177],"150":[183],"d.":[185],"Forty-five":[186],"percent":[187],"suggested":[195],"20-60":[199],"ng/mL":[200],"(47-140":[201],"nmol/L).":[202],"CONCLUSIONS:":[203],"show":[206],"4-fold":[208],"interindividual":[209],"difference":[210],"dose-adjusted":[212],"within":[215],"illustrate":[221],"age":[226],"induction":[229],"paliperidone.":[234],"also":[237],"indicates":[238],"that":[239],"least":[241],"some":[243],"patients,":[244],"it":[245],"might":[246],"take":[247],"longer":[248],"time":[249],"anticipated":[251],"reach":[253],"steady":[254],"state.":[255]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2017-11-10T00:00:00"}